AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. PNC
10. NEST:IN

Go back to AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH

Morgan Stanley on Amgen (AMGN): 'We believe the acquisition will be viewed as a modest positive'

August 4, 2022 10:03 AM EDT

Morgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $253.00 price target on Amgen (NASDAQ: AMGN).

The analyst comments "We believe the acquisition will be viewed as a modest positive given investors are looking for mgt. to expand the pipeline and near-term revenues.... More

ChemoCentryx (CCXI) to Resume Trading at 8:30 a.m.

August 4, 2022 8:07 AM EDT

ChemoCentryx (NASDAQ: CCXI) to Resume Trading at 8:30 a.m.

... More